Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938821 · ClinicalTrials.gov registry record
Very Low Dose Caudal Morphine for Postoperative Pain Management
A clinical trial of Caudal Anesthesia, sponsored by University of Oklahoma.
- Completed
- Registry status
- 33
- Enrollment target
- 1
- Study location
NCT00938821: Completed study of Caudal Anesthesia, sponsored by University of Oklahoma.
NCT00938821 is a study of Caudal Anesthesia that has completed, run by University of Oklahoma. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938821, a study of Caudal Anesthesia, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a chart review. The aim of this study is to investigate the effectiveness and side effects of very low dose morphine administered caudally to children that went to surgical procedures that used caudal anesthesia. The study compares caudal block with Bupivacaine (1 ml kg\_1 of bupivacaine 0.25% and saline 0.02 ml kg\_10) with very low dose morphine (a mix of 1 ml kg\_-1 of ropivacaine 0.2% and preservative-free morphine: 10 µg kg-1).
Conditions Studied
Interventions
- PROCEDURE Caudal block
Study Locations (1)
Oklahoma
- The University of Oklahoma Health Sciences Center Deparment of Anesthesiology - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-12-11 |
What the finished NCT00938821 record still lists
NCT00938821 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 1 condition, with Caudal Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Caudal block is the first listed.
NCT00938821 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT00938821 about?
NCT00938821 is a clinical study titled "Very Low Dose Caudal Morphine for Postoperative Pain Management". This is a chart review. The aim of this study is to investigate the effectiveness and side effects of very low dose morphine administered caudally to children that went to surgical procedures that used caudal anesthesia. The study compares caudal block with Bupivacaine (1 ml kg\_1 of bupivacaine 0.2...
What is the current status of trial NCT00938821?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2010-01. Estimated completion is 2012-12-11.
What conditions does trial NCT00938821 study?
This clinical trial studies the following conditions: Caudal Anesthesia.
What interventions are being tested in trial NCT00938821?
The interventions under investigation include: Caudal block (PROCEDURE).
Who is sponsoring clinical trial NCT00938821?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00938821 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia